Security
LENSAR, Inc. Common Stock · LNSR
LNSRNASDAQCommon stockCurrentCIK 1320350Updated Nov 11, 2026
Name history
LensAR Inc · through Jan 14, 2015LaserSoft Vision Inc · through Jun 16, 2006
LNSR price & chart
Loading TradingView…
NASDAQ:LNSR on TradingView ↗About the company
LENSAR is a commercial-stage medical device company focused on designing, developing, and marketing advanced systems for the treatment of cataracts and the management of astigmatism as an integral aspect of the procedure. LENSAR has developed its ALLY Robotic Cataract Laser System® as a compact, highly ergonomic system utilizing an extremely fast dual-modality laser and proprietary imaging and software. ALLY is designed to transform premium cataract surgery by utilizing LENSAR’s advanced robotic technologies with the ability to perform the entire procedure in a sterile operating room or in-office surgical suite, delivering operational efficiencies and reduced overhead. ALLY includes LENSAR’s proprietary Streamline® software technology, designed to guide surgeons to achieve better outcomes.
In the news
LENSAR® Provides Update on Pending Acquisition by Alcon ↗
$TOCKHOLDER ALERT: The M&A Class Action Firm Encourages Shareholders of SVT, SSBK, LNSR, iCAD to Protect Their Rights News provided by Monteverde & Associates PC Jun 10, 2025, 02:25 ET Share this article Share to X Share this article Share to X NEW YORK , June 10, 2025 /PRNewswire/ -- Monteverde & A ↗
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates TTNP, LNSR, ICAD on Behalf of Shareholders News provided by Halper Sadeh LLP Jun 09, 2025, 18:25 ET Share this article Share to X Share this article Share to X NEW YORK , June 9, 2025 /PRNewswire/ -- Halper Sadeh LLC, an investor rights law fi ↗
Seeking Alpha
These healthcare stocks have tumbled in 2026, yet Quant ratings stay positive ↗
Lensar anticipates introducing robotic docking features by end of Q1 2027 while recurring revenue reaches 89% of Q3 revenue ↗
LENSAR, Inc. (LNSR) Q3 2026 Earnings Call Transcript ↗
SEC disclosures
LENSAR, Inc. files 8-K: Material Event ↗
Recent filings
10-Q filing
Results of Operations and Financial Condition
Items 2.02, 9.01
10-Q filing
Results of Operations and Financial Condition
Items 2.02, 9.01
Submission of Matters to a Vote of Security Holders
Items 5.07
Show 5 more recent filings
Financials
FY 2025 · USDSource
Source
Source
Source
Source
Source
balance sheet · annual statements
| Line item | Q3 2025 | Q3 2024 | Q2 2026 | Q2 2025 | Q2 2024 | Q1 2026 | Q1 2025 | Q1 2024 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||||||
| AssetsUSD | 70,204,000Source | 62,019,000Source | 69,558,000Source | 70,414,000Source | 61,406,000Source | 66,223,000Source | 72,959,000Source | 66,134,000Source | 71,430,000Source | 66,297,000Source | 69,585,000Source | 55,844,000Source |
| Property, Plant and Equipment, NetUSD | 555,000Source | 677,000Source | 445,000Source | 609,000Source | 716,000Source | 457,000Source | 577,000Source | 747,000Source | 505,000Source | 664,000Source | 679,000Source | 563,000Source |
| Current assets: | ||||||||||||
| Cash and Cash Equivalents, at Carrying ValueUSD | 7,637,000Source | 10,442,000Source | 13,565,000Source | 7,150,000Source | 8,287,000Source | 12,494,000Source | 19,547,000Source | 13,958,000Source | 12,974,000Source | 16,263,000Source | 20,621,000Source | 14,674,000Source |
| Accounts Receivable, after Allowance for Credit Loss, CurrentUSD | 5,901,000Source | 4,373,000Source | 6,170,000Source | 4,987,000Source | 5,893,000Source | 4,896,000Source | 6,885,000Source | 4,023,000Source | 6,377,000Source | 6,085,000Source | 4,001,000Source | 6,040,000Source |
| Inventory, NetUSD | 20,596,000Source | 14,892,000Source | 24,871,000Source | 19,243,000Source | 17,933,000Source | 23,099,000Source | 15,324,000Source | 17,816,000Source | 21,520,000Source | 11,428,000Source | 15,689,000Source | 11,740,000Source |
| Assets, CurrentUSD | 44,429,000Source | 39,402,000Source | 47,026,000Source | 45,865,000Source | 40,229,000Source | 42,402,000Source | 49,186,000Source | 42,435,000Source | 46,771,000Source | 41,979,000Source | 46,444,000Source | 33,716,000Source |
| Prepaid Expense and Other Assets, CurrentUSD | 776,000Source | 1,705,000Source | 1,919,000Source | 991,000Source | 1,853,000Source | 625,000Source | 1,373,000Source | 2,357,000Source | 601,000Source | 1,616,000Source | 2,367,000Source | 1,062,000Source |
| Operating Lease, Right-of-Use AssetUSD | — | — | — | — | — | — | — | — | 2,556,000Source | 2,466,000Source | 2,141,000Source | 2,630,000Source |
| Other Assets, NoncurrentUSD | 2,929,000Source | 1,847,000Source | 2,357,000Source | 2,348,000Source | 1,965,000Source | 2,550,000Source | 2,477,000Source | 2,064,000Source | 2,747,000Source | 2,615,000Source | 2,207,000Source | 2,685,000Source |
| LIABILITIES AND EQUITY | ||||||||||||
| LiabilitiesUSD | 82,327,000Source | 25,497,000Source | 40,869,000Source | 79,682,000Source | 23,977,000Source | 41,649,000Source | 81,316,000Source | 20,552,000Source | 83,665,000Source | 47,651,000Source | 22,409,000Source | 13,860,000Source |
| Stockholders’ equity: | ||||||||||||
| Common Stock, Value, IssuedUSD | 119,000Source | 116,000Source | 123,000Source | 119,000Source | 115,000Source | 121,000Source | 118,000Source | 114,000Source | 120,000Source | 116,000Source | 113,000Source | 111,000Source |
| Retained Earnings (Accumulated Deficit)USD | -176,117,000Source | -124,593,000Source | -137,708,000Source | -172,404,000Source | -123,091,000Source | -141,243,000Source | -170,640,000Source | -114,048,000Source | -177,575,000Source | -143,295,000Source | -111,891,000Source | -97,508,000Source |
| Accumulated Other Comprehensive Income (Loss), Net of TaxUSD | 5,000Source | 15,000Source | 0Source | -3,000Source | -6,000Source | 0Source | 3,000Source | -1,000Source | 4,000Source | 6,000Source | 4,000Source | — |
| Stockholders' Equity Attributable to ParentUSD | -25,907,000Source | 22,738,000Source | 14,905,000Source | -23,052,000Source | 23,645,000Source | 10,790,000Source | -22,141,000Source | 31,835,000Source | -26,019,000Source | 4,862,000Source | 33,429,000Source | 41,984,000Source |
| Additional Paid in Capital, Common StockUSD | 150,086,000Source | 147,200,000Source | 152,490,000Source | 149,236,000Source | 146,627,000Source | 151,912,000Source | 148,378,000Source | 145,770,000Source | 151,432,000Source | 148,035,000Source | 145,203,000Source | 139,381,000Source |
| Liabilities and EquityUSD | 70,204,000Source | 62,019,000Source | 69,558,000Source | 70,414,000Source | 61,406,000Source | 66,223,000Source | 72,959,000Source | 66,134,000Source | 71,430,000Source | 66,297,000Source | 69,585,000Source | 55,844,000Source |
| Current liabilities: | ||||||||||||
| Liabilities, CurrentUSD | 35,725,000Source | 11,678,000Source | 19,640,000Source | 30,090,000Source | 10,366,000Source | 17,799,000Source | 27,174,000Source | 10,446,000Source | 40,574,000Source | 15,003,000Source | 11,632,000Source | 11,421,000Source |
| Operating Lease, Liability, CurrentUSD | 693,000Source | 574,000Source | 792,000Source | 522,000Source | 569,000Source | 785,000Source | 517,000Source | 564,000Source | 747,000Source | 524,000Source | 559,000Source | 531,000Source |
| Accounts Payable, CurrentUSD | 14,794,000Source | 3,867,000Source | 11,193,000Source | 11,314,000Source | 4,121,000Source | 10,097,000Source | 7,754,000Source | 4,120,000Source | 18,982,000Source | 5,995,000Source | 4,007,000Source | 5,422,000Source |
| Operating Lease, Liability, NoncurrentUSD | 2,187,000Source | 1,319,000Source | 1,589,000Source | 1,810,000Source | 1,464,000Source | 1,789,000Source | 1,956,000Source | 1,607,000Source | 1,988,000Source | 2,090,000Source | 1,750,000Source | 2,272,000Source |
| Other Liabilities, NoncurrentUSD | 911,000Source | 205,000Source | 874,000Source | 544,000Source | 262,000Source | 815,000Source | 616,000Source | 537,000Source | 909,000Source | 702,000Source | 570,000Source | 167,000Source |
| Additional Financial Items | ||||||||||||
| Accrued Liabilities, CurrentUSD | 7,894,000Source | 5,800,000Source | 4,728,000Source | 5,726,000Source | 4,262,000Source | 3,904,000Source | 6,910,000Source | 4,180,000Source | 7,771,000Source | 6,807,000Source | 5,717,000Source | 4,700,000Source |
| Deferred Revenue, CurrentUSD | 2,208,000Source | 1,437,000Source | 2,468,000Source | 2,528,000Source | 1,414,000Source | 2,503,000Source | 1,993,000Source | 1,582,000Source | 2,595,000Source | 1,677,000Source | 1,349,000Source | 768,000Source |
| Short-term InvestmentsUSD | 9,232,000Source | 7,638,000Source | 0Source | 13,159,000Source | 5,926,000Source | 1,001,000Source | 5,700,000Source | 3,952,000Source | 5,004,000Source | 6,192,000Source | 3,443,000Source | — |
cash flow · annual statements
| Line item | Q4 2025 | Q4 2024 | Q3 2025 | Q3 2024 | Q2 2026 | Q2 2025 | Q1 2026 | Q1 2025 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash flows from operating activities: | ||||||||||||
| Net Income (Loss), Including Portion Attributable to Noncontrolling InterestUSD | — | — | — | — | — | — | 36,332,000Source | -27,345,000Source | -34,280,000Source | -31,404,000Source | -14,383,000Source | -19,914,000Source |
| Adjustments to reconcile net income to net cash provided by operating activities: | ||||||||||||
| Share-based Payment Arrangement, Noncash ExpenseUSD | — | — | — | — | — | — | 690,000Source | 654,000Source | 3,143,000Source | 2,665,000Source | 5,539,000Source | 6,611,000Source |
| Changes in operating assets and liabilities: | ||||||||||||
| Increase (Decrease) in Accounts ReceivableUSD | — | — | — | — | — | — | -1,497,000Source | 743,000Source | 211,000Source | 2,189,000Source | -2,057,000Source | 1,440,000Source |
| Increase (Decrease) in InventoriesUSD | — | — | — | — | — | — | 2,146,000Source | 4,839,000Source | 13,899,000Source | 4,899,000Source | 7,461,000Source | 6,889,000Source |
| Increase (Decrease) in Accounts PayableUSD | — | — | — | — | — | — | -3,887,000Source | 1,759,000Source | 12,987,000Source | 1,956,000Source | -1,417,000Source | 2,729,000Source |
| Net Cash Provided by (Used in) Operating ActivitiesUSD | — | — | — | — | — | — | -4,271,000Source | -6,938,000Source | -14,831,000Source | -2,275,000Source | -9,659,000Source | -14,856,000Source |
| Cash flows from investing activities: | ||||||||||||
| Net Cash Provided by (Used in) Investing ActivitiesUSD | — | — | — | — | — | — | 4,000,000Source | 531,000Source | 1,284,000Source | -2,161,000Source | -4,156,000Source | -115,000Source |
| Payments to Acquire Property, Plant, and EquipmentUSD | — | — | — | — | — | — | — | 6,000Source | 83,000Source | 156,000Source | 236,000Source | 115,000Source |
| Cash flows from financing activities: | ||||||||||||
| Net Cash Provided by (Used in) Financing ActivitiesUSD | — | — | — | — | — | — | -209,000Source | 9,691,000Source | 10,258,000Source | 78,000Source | 19,762,000Source | -1,992,000Source |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate EffectUSD | — | — | — | — | — | — | -480,000Source | 3,284,000Source | -3,289,000Source | -4,358,000Source | 5,947,000Source | -16,963,000Source |
| Supplemental disclosure of cash flow information: | ||||||||||||
| Income Taxes Paid, NetUSD | — | — | — | — | — | — | — | — | 42,000Source | 24,000Source | 18,000Source | 3,000Source |
| Additional Financial Items | ||||||||||||
| Share-based Payment Arrangement, ExpenseUSD | — | — | 850,000Source | 668,000Source | 347,000Source | 766,000Source | 690,000Source | 654,000Source | — | 2,665,000Source | 5,539,000Source | 6,611,000Source |
| Amortization of Intangible AssetsUSD | — | — | 229,000Source | 232,000Source | 228,000Source | 230,000Source | 229,000Source | 232,000Source | 921,000Source | 970,000Source | 1,097,000Source | 1,148,000Source |
| DepreciationUSD | — | — | — | — | — | — | 904,000Source | 844,000Source | 3,581,000Source | 2,961,000Source | 2,418,000Source | 2,258,000Source |
| Gain (Loss) on Disposition of Property Plant EquipmentUSD | — | — | — | — | — | — | — | -58,000Source | -58,000Source | — | -7,000Source | -11,000Source |
| Impairment of Intangible Assets, Finite-livedUSD | — | — | — | — | — | — | — | — | 0Source | 3,729,000Source | 0Source | 0Source |
| Inventory Write-downUSD | — | — | — | — | — | — | — | — | 0Source | 94,000Source | 66,000Source | 50,000Source |
| Net Income (Loss) Attributable to ParentUSD | — | — | -3,713,000Source | -1,502,000Source | 3,535,000Source | -1,764,000Source | 36,332,000Source | -27,345,000Source | -34,280,000Source | -31,404,000Source | -14,383,000Source | -19,914,000Source |
| Net Income (Loss) Available to Common Stockholders, BasicUSD | — | — | -3,713,000Source | -1,502,000Source | 1,767,000Source | -1,764,000Source | 18,914,000Source | -27,345,000Source | -34,280,000Source | -31,404,000Source | -14,383,000Source | -19,914,000Source |
| Operating Costs and ExpensesUSD | — | — | 13,616,000Source | 7,511,000Source | 7,642,000Source | 13,313,000Source | 4,143,000Source | 12,915,000Source | 51,700,000Source | 36,516,000Source | — | — |
| Operating Lease, Lease IncomeUSD | — | — | 1,560,000Source | 1,724,000Source | 1,772,000Source | 1,645,000Source | 1,681,000Source | 1,884,000Source | 6,779,000Source | 7,532,000Source | 6,448,000Source | 5,915,000Source |
| Other Nonoperating Income (Expense)USD | — | — | 133,000Source | 153,000Source | 171,000Source | 193,000Source | 145,000Source | 159,000Source | 636,000Source | 660,000Source | 698,000Source | 263,000Source |
| Payments to Acquire InvestmentsUSD | — | — | — | — | — | — | — | 2,963,000Source | 11,878,000Source | 10,245,000Source | 3,920,000Source | — |
| Proceeds from Stock Options ExercisedUSD | — | — | — | — | — | — | 15,000Source | 21,000Source | 93,000Source | 58,000Source | — | — |
| Financing Receivable, Credit Loss, Expense (Reversal)USD | — | — | — | — | — | — | -2,000Source | -5,000Source | -10,000Source | -2,000Source | 20,000Source | 10,000Source |
| Interest Paid, Excluding Capitalized Interest, Operating Activities | — | — | — | — | — | — | — | —Source | — | — | — | — |
| Impairment of Intangible Assets (Excluding Goodwill) | — | — | — | — | — | — | — | — | — | — | — | — |
| Income Tax Expense (Benefit) | — | — | —Source | —Source | —Source | —Source | —Source | —Source | — | — | — | — |
income statement · annual statements
| Line item | Q4 2025 | Q4 2024 | Q3 2025 | Q3 2024 | Q2 2026 | Q2 2025 | Q1 2026 | Q1 2025 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total RevenueUSD | — | — | 12,756,000Source | 11,815,000Source | 14,723,000Source | 12,290,000Source | 11,747,000Source | 12,275,000Source | 51,656,000Source | 45,962,000Source | 35,716,000Source | 29,443,000Source |
| Cost of Goods and Services Sold | — | — | —Source | —Source | —Source | —Source | —Source | —Source | —Source | —Source | —Source | —Source |
| Gross Profit (Calculated) · Derived | — | — | — | — | — | — | — | — | — | — | — | — |
| Selling, General and Administrative ExpenseUSD | — | — | 12,020,000Source | 6,077,000Source | 6,141,000Source | 11,658,000Source | 2,529,000Source | 11,149,000Source | 45,157,000Source | 26,488,000Source | 26,100,000Source | 27,170,000Source |
| Operating Income (Loss)USD | — | — | -7,580,000Source | -1,245,000Source | 2,134,000Source | -6,289,000Source | 2,239,000Source | -5,790,000Source | -24,578,000Source | -10,665,000Source | -12,229,000Source | -20,177,000Source |
| Other Nonoperating Income (Expense)USD | — | — | 133,000Source | 153,000Source | 171,000Source | 193,000Source | 145,000Source | 159,000Source | 636,000Source | 660,000Source | 698,000Source | 263,000Source |
| Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling InterestUSD | — | — | — | — | — | — | — | — | -34,280,000Source | -31,404,000Source | -14,383,000Source | -19,914,000Source |
| Net Income (Loss) Attributable to ParentUSD | — | — | -3,713,000Source | -1,502,000Source | 3,535,000Source | -1,764,000Source | 36,332,000Source | -27,345,000Source | -34,280,000Source | -31,404,000Source | -14,383,000Source | -19,914,000Source |
| Earnings Per Share, BasicUSD per share | — | — | -0.31Source | -0.13Source | 0.14Source | -0.15Source | 1.56Source | -2.32Source | -2.87Source | -2.73Source | -1.31Source | -1.96Source |
| Earnings Per Share, DilutedUSD per share | — | — | -0.31Source | -0.13Source | 0.1Source | -0.15Source | 0Source | -2.32Source | -2.87Source | -2.73Source | -1.31Source | -1.96Source |
| Weighted Average Number of Shares Outstanding, Basicshares | — | — | 12,044,000Source | 11,604,000Source | 12,297,000Source | 11,937,000Source | 12,161,000Source | 11,774,000Source | 11,958,000Source | 11,518,000Source | 10,971,000Source | 10,159,000Source |
| Weighted Average Number of Shares Outstanding, Dilutedshares | — | — | 12,044,000Source | 11,604,000Source | 23,027,000Source | 11,937,000Source | 15,420,000Source | 11,774,000Source | 11,958,000Source | 11,518,000Source | 10,971,000Source | 10,159,000Source |
| Additional Financial Items | ||||||||||||
| Amortization of Intangible AssetsUSD | — | — | 229,000Source | 232,000Source | 228,000Source | 230,000Source | 229,000Source | 232,000Source | 921,000Source | 970,000Source | 1,097,000Source | 1,148,000Source |
| Business Combination, Acquisition Related CostsUSD | — | — | 5,275,000Source | — | — | 4,174,000Source | 8,656,000Source | 4,225,000Source | 17,141,000Source | — | — | — |
| Income (Loss) from Continuing Operations before Income Taxes, DomesticUSD | — | — | — | — | — | — | — | — | -34,280,000Source | -31,404,000Source | -14,383,000Source | -19,914,000Source |
| Lease IncomeUSD | — | — | 1,560,000Source | 1,724,000Source | 1,772,000Source | 1,645,000Source | 1,681,000Source | 1,884,000Source | 6,779,000Source | 7,532,000Source | 6,448,000Source | 5,915,000Source |
| Net Income (Loss) Available to Common Stockholders, BasicUSD | — | — | -3,713,000Source | -1,502,000Source | 1,767,000Source | -1,764,000Source | 18,914,000Source | -27,345,000Source | -34,280,000Source | -31,404,000Source | -14,383,000Source | -19,914,000Source |
| Operating Costs and ExpensesUSD | — | — | 13,616,000Source | 7,511,000Source | 7,642,000Source | 13,313,000Source | 4,143,000Source | 12,915,000Source | 51,700,000Source | 36,516,000Source | — | — |
| Operating Lease, Lease IncomeUSD | — | — | 1,560,000Source | 1,724,000Source | 1,772,000Source | 1,645,000Source | 1,681,000Source | 1,884,000Source | 6,779,000Source | 7,532,000Source | 6,448,000Source | 5,915,000Source |
| Research and Development ExpenseUSD | — | — | 1,367,000Source | 1,202,000Source | 1,273,000Source | 1,425,000Source | 1,385,000Source | 1,534,000Source | 5,622,000Source | 5,329,000Source | 6,139,000Source | 11,814,000Source |
| Income Tax Expense (Benefit) | — | — | —Source | —Source | —Source | —Source | —Source | —Source | — | — | — | — |
| Undistributed Earnings (Loss) Allocated to Participating Securities, Basic | — | — | — | — | — | — | —Source | — | — | — | — | — |
Filing attachments
lnsr-ex99_1.htm · 8-K · 2026-11-10
Exhibit 99.1 LENSAR® Reports Third Quarter 2026 Financial Results and Provides Business Update 10 ALLY Robotic Cataract Laser Systems® (“ALLY System”) Placements in Third Quarter 2026; Backlog of 12 ALLY Systems as of September 30, 2026 Third Quarter Recurring Revenue Grew 17% Year Over Year to $12.6 Million Total Laser Installed Base Reaches 450 Systems; ALLY System Installed Base Expands 22% Year Over Year ORLANDO, Fla. (Nov 10, 2026) - LENSAR, Inc. (Nasdaq: LNSR) (“LENSAR” or the “Compan…
Read attachment ↗lnsr-ex99_1.htm · 8-K · 2026-08-13
EX-99.1 2 lnsr-ex99_1.htm EX-99.1 EX-99.1 Exhibit 99.1 LENSAR® Reports Second Quarter 2026 Results and Provides Business Update 10 ALLY Robotic Cataract Laser Systems® (“ALLY System”) Placements in Second Quarter 2026; Backlog of 13 ALLY Systems as of June 30, 2026 Second Quarter Recurring Revenue was $13.7 million Total Laser Installed Base Climbs to 445 Systems, Driven by 30% Growth in ALLY Placements ORLANDO, Fla. (Aug 13, 2026) - LENSAR, Inc. (Nasdaq: LNSR) (“LENSAR” or the “Compan…
Read attachment ↗lnsr-ex99_1.htm · 8-K · 2026-05-08
EX-99.1 2 lnsr-ex99_1.htm EX-99.1 EX-99.1 Exhibit 99.1 LENSAR® Reports First Quarter 2026 Results and Provides Business Update 7 ALLY Robotic Cataract Laser Systems® (“ALLY System”) Placements in First Quarter 2026; Backlog of 11 ALLY Systems as of March 31, 2026 First Quarter Recurring Revenue was $12.6 million Total Laser Installed Base Climbs to 440 Systems, Driven by 39% Growth in ALLY Placements ORLANDO, Fla. (May 8, 2026) - LENSAR, Inc. (Nasdaq: LNSR) (“LENSAR” or the “Company”),…
Read attachment ↗lnsr-ex99_1.htm · 8-K · 2026-03-31
EX-99.1 2 lnsr-ex99_1.htm EX-99.1 EX-99.1 Exhibit 99.1 LENSAR® Reports Fourth Quarter and Full Year 2025 Results and Provides Business Update 15 ALLY Robotic Cataract Laser Systems® (“ALLY Systems”) placed in 4Q 2025; Backlog of 13 ALLY Systems pending installation as of December 31, 2025 ALLY installed base grew 48%, total laser installed base grew 13% over December 31, 2024 Recurring revenue exceeded $46.3 million for the full year; increased 15% over 2024 ORLANDO, Fla. (March 31, 20…
Read attachment ↗d27242dex991.htm · 8-K · 2026-03-17
EX-99.1 3 d27242dex991.htm EX-99.1 EX-99.1 Exhibit 99.1 LENSAR® Announces Termination of Merger Agreement with Alcon Research, LLC Company to Report Fourth Quarter Financial Results and Provide Strategic Update on March 31, 2026 ORLANDO, Fla., March 16, 2026 (GLOBE NEWSWIRE) - LENSAR, Inc. (Nasdaq: LNSR) (“LENSAR” or the “Company”), a global medical technology company focused on advanced robotic laser solutions for the treatment of cataracts, announced that it reached an agreement with A…
Read attachment ↗d115210dex991.htm · 8-K · 2026-02-25
EX-99.1 2 d115210dex991.htm EX-99.1 EX-99.1 Exhibit 99.1 LENSAR ® Provides Update on Pending Acquisition by Alcon ORLANDO, Fla. (February 25, 2026) - LENSAR, Inc. (Nasdaq: LNSR) (“LENSAR” or the “Company”), a global medical technology company focused on advanced robotic laser solutions for the treatment of cataracts, today provided an update on the status of its pending acquisition by Alcon Research, LLC (“Alcon”). The Company and Alcon continue to cooperate with the U.S. Federal Trade C…
Read attachment ↗